Although these observations require confirmation in further studies of the roles of LKB1 and AMPK, consequent improvements in understanding of selective BRAF inhibitor-induced autophagy may lead to improved therapeutic strategies for patients with BRAFV600E CRC. This evidence concerns the gene BRAF and colorectal carcinoma.